"In Flemingsberg, we cure diseases that were previously considered incurable"


JOHNNY HÖGBERG: ATMP (Advanced Therapy Medicinal Products) has proven to be a revolution in healthcare by offering remedies for diseases that were previously considered incurable. Flemingsberg has been a pioneer in the field of ATMP since 1996, thanks to Karolinska University Hospital in Huddinge, one of Europe's largest hospitals, and Karolinska Institutet. Their collaboration creates a medical center with a high international reputation and continues to drive innovation in advanced therapies.

Swedish version >>

Flemingsberg is a dynamic and multidisciplinary place where collaboration between hospital, academia and industry continues to flourish, resulting in groundbreaking advances in Swedish cell therapy. Over time, Campus Flemingsberg has grown to accommodate almost 20,000 students and become a versatile knowledge hub with five colleges and universities, an art school and an upper secondary school. The geographical proximity between academies and hospitals has created unique conditions for life science companies to establish themselves in the area. The hospital's robust infrastructure has attracted companies that can conduct their research with the support of the existing expertise in Flemingsberg.

Thanks to the vibrant life science ecosystem, Flemingsberg has become a unique place. Close cooperation and the exchange of knowledge and innovation has not only created a dynamic environment, but also positioned Flemingsberg as one of the leading destinations in the Life Science sector.

Flemingsberg is also undergoing dynamic urban development with plans for around 10,000 new homes and the development of a university town, as well as the Stockholm South Business District as an international business and research hub. Karolinska Institutet and the University Hospital offer a strong infrastructure through their Core Facilities, which are constantly updated with the latest technologies and knowledge in research. Flemingsberg is the perfect place for knowledge-intensive companies with a developed infrastructure for commercialization and collaborative projects.

Read more on: